欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5281/001
药品名称Dexmedetomidine Seacross 100 microgram/ml concentraat voor oplossing voor Infusie
活性成分
    • Dexmedetomidine hydrochloride 100.0 µg/ml
剂型Concentrate for solution for infusion
上市许可持有人Seacross Pharma (Europe) Limited POD 13, The Old Station House, 15A Main Street, Blackrock, Dublin, A94 T8P8 Ireland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      Dexmedetomidin YRPG
许可日期2024/07/09
最近更新日期2025/09/10
药物ATC编码
    • N05CM18 dexmedetomidine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase